Biography

Dr. Joseph J. Carter

Fred Hutchinson Cancer Research Center, USA


Email: [email protected]


Qualifications

Ph.D., Biochemistry, Washington State University, USA

B.S., Chemistry, Lewis and Clark College, USA


Publications (selected)

  1. Salisbury, N. J., Amonkar, S., Landazuri Vinueza, J., Carter, J. J., Roman, A., & Galloway, D. A. (2024). Polyomavirus ALTOs, but not MTs, downregulate viral early gene expression by activating the NF-κB pathway. Proceedings of the National Academy of Sciences, 121(34), e2403133121.
  2. Buchta Rosean, C., Leyder, E. C., Hamilton, J., Carter, J. J., Galloway, D. A., Koelle, D. M., ... & Heiland, T. (2023). LAMP1 targeting of the large T antigen of Merkel cell polyomavirus results in potent CD4 T cell responses and tumor inhibition. Frontiers in Immunology, 14, 1253568.
  3. Prabhu, P. R., Carter, J. J., & Galloway, D. A. (2022). B cell responses upon human papillomavirus (HPV) infection and vaccination. Vaccines, 10(6), 837.
  4. Whaley, R. E., Ameny, S., Arkatkar, T., Seese, A., Wall, A., Khan, I., ... & McGuire, A. T. (2021). Generation of a cost-effective cell line for support of high-throughput isolation of primary human B cells and monoclonal neutralizing antibodies. Journal of Immunological Methods, 488, 112901.
  5. Paulson, K. G., Lewis, C. W., Redman, M. W., Simonson, W. T., Lisberg, A., Ritter, D., ... & Nghiem, P. (2017). Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: a prospective validation study. Cancer, 123(8), 1464-1474.
  6. Fu, T. C., Carter, J. J., Hughes, J. P., Feng, Q., Hawes, S. E., Schwartz, S. M., ... & Winer, R. L. (2016). Re‐detection vs. new acquisition of high‐risk human papillomavirus in mid‐adult women. International journal of cancer, 139(10), 2201-2212.
  7. Colombara, D. V., Manhart, L. E., Carter, J. J., Hawes, S. E., Weiss, N. S., Hughes, J. P., ... & Galloway, D. A. (2016). Absence of an association of human polyomavirus and papillomavirus infection with lung cancer in China: a nested case–control study. BMC cancer, 16, 1-11.
  8. Scherer, E. M., Smith, R. A., Gallego, D. F., Carter, J. J., Wipf, G. C., Hoyos, M., ... & Galloway, D. A. (2016). A single human papillomavirus vaccine dose improves B cell memory in previously infected subjects. EBioMedicine, 10, 55-64.
  9. Colombara, D. V., Manhart, L. E., Carter, J. J., Hawes, S. E., Weiss, N. S., Hughes, J. P., ... & Galloway, D. A. (2015). Prior human polyomavirus and papillomavirus infection and incident lung cancer: a nested case–control study. Cancer Causes & Control, 26, 1835-1844.
  10. Daling, J.R., Madeleine, M.M., Schwartz, S.M., Shera, K.A., Carter, J.J., McKnight, B., Porter, P.L., Galloway, D.A., McDougall J.K., Tamimi H. A Population-Based Study of Squamous Cell Vaginal Cancer: HPV and Cofactors Gynecol Oncol. 84: 263-270 2002.
  11. Xi L.F., Carter J.J., Galloway D.A.., Kuypers J., Hughes, J.P., Lee, S.K., Adam, D.E., Kiviat, N.B., Koutsky L.A.. Acquisition and Natural History of Human Papillomavirus Type 16 Variant Infection among a Cohort of Female University Students. Cancer Epidemiology, Biomarkers & Prevention 11(4):343-51. 2002.
  12. Madeleine M.M., Daling J.R., Schwartz D.M., Shera, K., McKnight, B., Carter J.J., Wipf G.C., Critchlow C.W., McDougall J.K., Porter P., Galloway D.A. Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix. Cancer Epidemiology, Biomarkers & Prevention. 10(3): 171-177. 2001.
  13. Carter J.J., Madeleine M.M., Shera, K., Schwartz D.M., Cushing-Haugen, K,L., Wipf G.C., Porter P., Daling J.R., McDougall J.K., Galloway D.A.. Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites. Cancer Research. 61:1934-1940. 2001.
  14. Madeleine M.M., Shera, K., Schwartz D.M., Daling J.R., Galloway D.A Wipf G.C., Carter J.J., McKnight, B., McDougall J.K.. The p53 Arg72Pro polymorphism, human papillomavirus, and invasive squamous cell cervical cancer. Cancer Epidemiology, Biomarkers & Prevention. 9(2): 225-227. 2000.
  15. Carter J.J., Koutsky L.A., Hughes J.P., Lee S-K., Kuypers J., Kiviat N., Galloway D.A. Comparison of HPV 16, 18 and 6 capsid antibody responses following incident infection. Journal of Infectious Diseases. J. Infec. Dis. 181(6): 1911-1919. 2000.
  16. Schwartz S.M., Daling J.R., Doody D.R., Wipf G.C., Carter J.J., Madeleine M.M., Mao E.J., Fitzgibbons E.D., Huang S., Beckmann A.M., McDougall J.K., Galloway D.A.. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst 90(21): 1626-1636. 1998.
  17. Carter, J.J., Galloway, D.A. Humoral Immune Response to Human Papillomavirus Infection. In: “Papillomaviruses: clinics in dermatology” Eds. S. Jablonska and G. Orth, Elsevier Science 15(2): 249-259. 1997.
  18. Madeleine, M.M., Daling, J.R., Schwartz, S.M., Carter, J.J., Wipf, G.C., McKnight, B., Kurman, R.J., Ashley, R., Beckmann, A.M., Sherman, K.J., Galloway, D.A. HSV2 and smoking: potential cofactors with HPV in a population-based study of vulvar cancer. Cancer Epidemiology, Biomarkers and Prevention. J. Nat. Cancer Inst. 89(20): 1516-1522. 1997.
  19. Christensen, N.D., Dillner, J., Carter, J.J., Wipf, G.C., Reed, C.A., Cladel, N.M., Galloway, D.A. Surface conformational and linear epitopes on HPV 16 and HPV 18 virus-like particles as defined by monoclonal antibodies. Virology 223(1): 174-184. 1996.
  20. Carter, J.J. Koutsky, L.A., Wipf, G.C., Christensen, N.D., Lee, S-K. Kuypers, J., Kiviat, N.B., Galloway, D.A. The natural history of HPV 16 capsid antibodies among a cohort of university women. J. Infectious Diseases 174(5): 927-936. 1996.
  21. Daling, J.R., Madeleine, M.M., McKnight, B., Carter, J.C. Schwartz, S.M., Beckmann, A.M., Mandelson, M.T., Galloway, D.A. The relationship of human papillomavirus - related cervical tumors to cigarette smoking, oral contraceptive use and prior herpes simplex -2 infection. Cancer, Epidemiology, Biomarkers & Prevention 5:541-548. 1996
  22. Hagensee, M.E., Carter, J.J., Wipf, G.C. and Galloway, D.A. Serologic response in mice to vaccinia-virus produced HPV-1 capsids. Virology 206(1): 174-182. 1995.
  23. Carter, J.J., Wipf, G., Hagensee, M.E., Taflin, M.C., McKnight, B., Habel, L.A., Lee, S.K., Kuypers, J., Kiviat, N. Daling, J.R., Koutsky, L.A., Watts, D.H., Holmes, K.K. and Galloway, D.A. Use of human papillomavirus type 6 capsids to detect antibodies in people with genital warts. Journal of Infectious Diseases 172(1): 11-18. 1995.
  24. Hagensee, M.E., Carter, J.J., Wipf, G.P., and Galloway, D.A. Immunization of mice with HPV- vaccinia virus recombinants generates serum IgG, IgM, and mucosal IgA antibodies. Virology 206:174-182. 1995.
  25. Carter, J.J., Hagensee, M.E., Lee, S.K., McKnight, B., Koutsky, L.A. and Galloway, D.A. Use of HPV-1 capsids produced by recombinant vaccinia viruses in an ELISA to detect serum antibodies in people with foot warts. Virology 199: 284-291. 1994.
  26. Carter, J.J., Hagensee, M., Taflin, M.C., Lee, S.K., Koutsky, L.A. and Galloway, D.A. HPV-1 capsids expressed in vitro detect human serum antibodies associated with foot warts. Virology 195:456-462. 1993.
  27. Carter, J.J., Yaegashi, N., Jenison, S.A. and Galloway, D.A. Expression of human papillomavirus proteins in yeast Saccharomyces cerevisiae. Virology 182:513-521. 1991.
  28. Carter, J.J., Weinberg, A.D., Pollard, A., Reeves, R., Magnuson, J.A. and Magnuson, N.S. Inhibition of T-lymphocyte mitogenic responses and effects on cell functions by bovine herpesvirus 1. Journal of Virology 63:1525-1530. 1989.
  29. Carter, J., Magnuson, N.S., Davis, W.C., Mason, P.H., Magnuson, J.A., Tallmadge, J.E. and Barr, P.J. Development and maintenance of bovine cytotoxic lymphocytes with recombinant interleukin-2. Virology 57:123-129. 1986.


Profile Details

https://scholar.google.com/citations?user=eQ8JkI8AAAAJ&hl=en&oi=ao
https://www.researchgate.net/scientific-contributions/Joseph-J-Carter-2184060791

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top